000 | 00679cam a2200229 4500 | ||
---|---|---|---|
001 | 1842572989 | ||
008 | 090401t2003 xxu||||| |||| 00| 0 eng d | ||
020 | _a1842572989 | ||
082 | _a616.99449 NAT | ||
110 | _aNational Institute for Clinical Excellence | ||
245 | _aGuidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer | ||
260 |
_aLondon : _bNational Institute of Clinical Excellence, _c2003 |
||
490 | _aTechnology Appraisal | ||
490 | _a62 | ||
500 | _aOncology | ||
650 |
_aClinical Medicine _91273 |
||
650 | _aOncology | ||
650 | _aBreast Cancer | ||
942 |
_cBKSTD _n0 |
||
996 | _a24p | ||
997 | _a0 | ||
999 |
_c89647 _d89647 |